Nasdaq · CIK 0001228454
BCBP BCB BANCORP INC
Insider trading from SEC Form 4. Last filing 21 d ago. Close $8.23 on Oct 9, 2026, +12% from the 52-week low and -28% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BCB BANCORP INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Jawad Chaudhry CHIEF FINANCIAL OFFICER buy | $78k 10,000 shares | +19% | - | |
| 64Notable | Thomas M OBrien CHIEF EXECUTIVE OFFICER buy | $1.2M 160,000 shares | +23% | - | |
| 32Weak | Gerald Werdann director buy | $50k 4,400 shares | +57% | +56% from low-1% from high | |
| 38Weak | Mark D Hogan director buy | $40k 5,000 shares | +5% | +9% from low-16% from high | |
| 22Weak | Michael J Widmer director buy | $17k 2,000 shares | +19% | +14% from low-15% from high | |
| 53Moderate | James G. Rizzo director buy | $15k 2,000 shares | +3% | 0% from low-41% from high | |
| 51Moderate | Joseph Lyga director buy | $2,926 380 shares | +14% | 0% from low-41% from high | |
| 61Notable | Mark D Hogan director buy | $77k 10,000 shares | +2% | 0% from low-41% from high | |
| 53Moderate | Mark D Hogan director buy | $80k 10,000 shares | +11% | 0% from low-39% from high | |
| 44Moderate | James G. Rizzo director buy | $24k 3,000 shares | +5% | +2% from low-38% from high | |
| 35Weak | Ryan Blake Chief Operating Officer sell | $113k 8,677 shares | -18% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 2, 2024 | Blake Ryan Officer | 10,000 0.06% of outstanding | $133k | Dec 2, 2024 | none |
Transactions
The last 37 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Thomas M OBrien CHIEF EXECUTIVE OFFICER | POpen-market purchase Common Stock | +160,000 | $7.75 | $1.2M | 869,220 | 21 d ago |
| Sep 18, 2026 | Jawad Chaudhry CHIEF FINANCIAL OFFICER | POpen-market purchase Common Stock | +10,000 | $7.75 | $78k | 62,500 | 21 d ago |
| Jun 3, 2026 | Ryan Blake CHIEF OPERATING OFFICER | IDiscretionary transaction Common Stockindirect: 401(k) Plan | -5,841 | $11.11 | $65k | 1,112 | Jun 18, 2026 |
| Jun 4, 2026 | Gerald Werdann director | POpen-market purchase Common Stockindirect: BGJ Family Trust | +4,400 | $11.28 | $50k | 12,122 | Jun 5, 2026 |
| Apr 22, 2026 | Gerald Werdann director | AGrant or award Common Stock | +4,226 | $9.86 | $42k | 4,226 | Apr 24, 2026 |
| Feb 27, 2026 | Mark D Hogan director | POpen-market purchase Common Stockindirect: By IRA | +5,000 | $7.97 | $40k | 103,352 | Mar 2, 2026 |
| Feb 10, 2026 | John Pulomena director | AGrant or award Common Stock | +5,952 | $0.00 | $0 | 27,052 | Feb 12, 2026 |
| Feb 10, 2026 | Vincent DiDomenico Jr director | AGrant or award Common Stock | +5,952 | $0.00 | $0 | 186,582 | Feb 12, 2026 |
| Feb 10, 2026 | Judith Q Bielan director | AGrant or award Common Stock | +5,952 | $0.00 | $0 | 120,504 | Feb 12, 2026 |
| Feb 10, 2026 | James G. Rizzo director | AGrant or award Common Stock | +5,952 | $0.00 | $0 | 68,660 | Feb 12, 2026 |
| Feb 10, 2026 | Joseph Lyga director | AGrant or award Common Stock | +5,952 | $0.00 | $0 | 187,695 | Feb 12, 2026 |
| Feb 10, 2026 | Mark D Hogan director | AGrant or award Common Stock | +5,952 | $0.00 | $0 | 627,092 | Feb 12, 2026 |
| Feb 10, 2026 | Tara L French director | AGrant or award Common Stock | +5,952 | $0.00 | $0 | 13,142 | Feb 12, 2026 |
| Feb 10, 2026 | Michael J Widmer director | AGrant or award Common Stock | +5,952 | $0.00 | $0 | 10,642 | Feb 12, 2026 |
| Feb 10, 2026 | Michael J Widmer director | POpen-market purchase Common Stock | +2,000 | $8.40 | $17k | 12,642 | Feb 12, 2026 |
| Feb 24, 2025 | Sandra Sievewright Chief Compliance Officer | AGrant or award Option to purchasederivative | +7,185 | $0.00 | $0 | 7,185 | Oct 17, 2025 |
| Feb 24, 2025 | Jawad Chaudhry Chief Financial Officer | MOption exercise Option to purchasederivative | +15,267 | $0.00 | $0 | 15,267 | Aug 1, 2025 |
| Feb 24, 2025 | Michael A Shriner Chief Executive Officer | MOption exercise Option to purchasederivative | +26,942 | $0.00 | $0 | 26,942 | Aug 1, 2025 |
| Feb 24, 2025 | Ryan Blake Chief Operating Officer | MOption exercise Option to purchasederivative | +14,369 | $0.00 | $0 | 14,369 | Aug 1, 2025 |
| Jun 13, 2025 | Mark D Hogan director | POpen-market purchase Common Stock | +10,000 | $7.74 | $77k | 621,140 | Jun 16, 2025 |
| Jun 13, 2025 | Joseph Lyga director | POpen-market purchase Common Stockindirect: By spouse | +280 | $7.70 | $2,156 | 2,920 | Jun 16, 2025 |
| Jun 13, 2025 | James G. Rizzo director | POpen-market purchase Common Stock | +2,000 | $7.70 | $15k | 62,708 | Jun 16, 2025 |
| Jun 13, 2025 | Joseph Lyga director | POpen-market purchase Common Stockindirect: By child | +100 | $7.70 | $770 | 3,208 | Jun 16, 2025 |
| May 23, 2025 | Mark D Hogan director | POpen-market purchase Common Stockindirect: By IRA | +10,000 | $8.04 | $80k | 98,352 | May 27, 2025 |
| May 27, 2025 | James G. Rizzo director | POpen-market purchase Common Stock | +1,500 | $8.05 | $12k | 60,708 | May 27, 2025 |
| May 27, 2025 | James G. Rizzo director | POpen-market purchase Common Stockindirect: By IRA | +1,500 | $8.05 | $12k | 73,554 | May 27, 2025 |
| Feb 3, 2025 | Thomas Michael Coughlin director | AGrant or award Common Stock | +1,563 | $0.00 | $0 | 246,979 | Feb 5, 2025 |
| Feb 3, 2025 | Michael J Widmer director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 4,690 | Feb 5, 2025 |
| Feb 3, 2025 | Raymond Vanaria director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 5,690 | Feb 5, 2025 |
| Feb 3, 2025 | James G. Rizzo director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 59,208 | Feb 4, 2025 |
| Feb 3, 2025 | Tara L French director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 7,190 | Feb 4, 2025 |
| Feb 3, 2025 | Mark D Hogan director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 611,140 | Feb 4, 2025 |
| Feb 3, 2025 | John Pulomena director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 21,100 | Feb 4, 2025 |
| Feb 3, 2025 | Joseph Lyga director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 180,400 | Feb 4, 2025 |
| Feb 3, 2025 | Judith Q Bielan director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 111,852 | Feb 4, 2025 |
| Feb 3, 2025 | Vincent DiDomenico Jr director | AGrant or award Common Stock | +4,690 | $0.00 | $0 | 180,630 | Feb 4, 2025 |
| Dec 3, 2024 | Ryan Blake Chief Operating Officer | SOpen-market sale Common Stock | -8,677 | $13.06 | $113k | 39,362 | Dec 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Judith Q Bielandirector
- Ryan BlakeCHIEF OPERATING OFFICER
- Thomas Michael Coughlindirector
- Jawad ChaudhryChief Financial Officer
- Vincent DiDomenico Jrdirector
- Tara L Frenchdirector
- Mark D Hogandirector
- Joseph Lygadirector
- Thomas M OBrienCHIEF EXECUTIVE OFFICER
- John Pulomenadirector
- James G. Rizzodirector
- Michael A ShrinerChief Executive Officer
- Sandra SievewrightChief Compliance Officer
- Raymond Vanariadirector
- Gerald Werdanndirector
- Michael J Widmerdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.